This is a one-of-a-kind event that is a unique opportunity for CEO's and Senior Executives to discuss the critical issues that affect product commercialization, and the common challenges faced by medtech companies today.
Industry experts and government offices will address investment options, FDA reform, reimbursement challenges and much more.
Topics to be Addressed:
- MDUFA Update and FDA Reform Update
- Commercializing in Difficult Economic Times
- 2012 Election Update
- Key Reimbursement Issues
- Launching Overseas
- Effectively Engaging in Washington
- Compliance, Trends & Strategies